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We thank Poignant and Laffon (1) for their letter outlining where they feel our research contributes to patient care. As the authors mention, current 
research has demonstrated variable benefits related to the use 
of continuous infusion 3% hypertonic saline (HTS) in neuro-
critical care. They have raised several valid points that we feel 
require further commentary.
Overall, the current body of evidence evaluating continu-
ous infusion HTS is mainly limited to single-center studies with 
small patient samples. Although the randomized, double-blind 
study referenced by Poignant did demonstrate a potential ben-
efit of an induced hyperosmolar hypernatremic state, it included 
only 30 patients receiving this intervention. Patients in this study 
received a half-molar sodium lactate infusion and had lower 
serum chloride levels than the control group (2). Notably, our 
study of intracerebral hemorrhage (ICH) patients found no 
association, positive or negative, with hypernatremia and mor-
tality (3). Wagner et al (4) retrospectively reported that the use 
of continuous 3% HTS significantly decreased cerebral edema 
volume and occurrences of intracranial pressure crisis, but only 
26 patients received continuous 3% HTS. In the referenced study 
by Qureshi et al (5), use of continuous HTS was a positive pre-
dictor of in-hospital mortality in 36 head trauma patients. An 
earlier study by the same authors evaluated the use of a mixed 
HTS/acetate continuous infusion on a cohort of 27 patients that 
included those with head trauma, ICH, ischemic stroke, and 
postoperative cerebral edema. It revealed possible benefits in 
those with head trauma and postoperative edema, but these data 
are even more limited considering only 13 patients had these 
types of injuries (6). While there have been several other studies 
on the subject, there still remains a paucity of data showing ben-
efits of this therapy, yet the practice seems to be one that is widely 
used to reduce cerebral edema and limit episodes of intracranial 
hypertension across a broad range of neurologic injuries. In fact, 
no major guideline related to neurocritical care recommends 
this therapy with even a moderate level of evidence.
While this practice requires further study, we also feel that 
studies are needed regarding hyperchloremia in those with 
severe neurologic injuries. Our analysis of patients with ICH 
supports a recent publication that demonstrated an association 
between hyperchloremia and increased rates of acute kidney 
in subarachnoid hemorrhage (7). The impact of hyperchlore-
mia on acute ischemic stroke and traumatic brain injury are of 
equal interest and currently lack sufficient evaluations. Addi-
tionally, clinicians would benefit from studies aimed at iden-
tifying predictors of hyperchloremia in all the aforementioned 
populations. Does the use of continuous infusion 3% HTS 
increase the likelihood of hyperchloremia? Is hyperchloremia 
an indicator of disease severity or prescribing bias? Does the use 
of balanced mixtures of HTS lead to less hyperchloremia and 
reduced adverse effects? Should total volume of chloride-based 
fluids be monitored, including fluids from medication admix-
tures? All these questions remain unanswered based upon the 
current available evidence and require further evaluation.
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Burnout Research: Eyes Wide Shut
To the Editor:
In a study published in a recent issue of Critical Care Medi-cine, Colville and Smith (1) found modest overlap between burnout and depression and assumed that burnout and 
depression are distinct entities. We think that the conducted 
study is seriously flawed.
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First, Colville and Smith (1) assessed burnout symptoms 
with an abbreviated version of the Maslach Burnout Inven-
tory (MBI), the psychometric properties of which are unclear. 
Second, the authors used clinically and theoretically arbitrary 
cutoff scores for categorizing burnout—a modus operandi that, 
unfortunately, has become commonplace in studies of medi-
cal professionals (2). Third, participants could be categorized 
as “burned out” without showing any sign of exhaustion—a 
troubling choice given that, as emphasized by Maslach et al (3), 
“exhaustion is a necessary criterion for burnout” (p. 403). Major 
methodological problems thus undermine the conducted study.
The authors partly recognized that major problems affected 
their study when lamenting the “enormous variability” in their 
estimates of burnout’s “prevalence”—from 6% to 60%—as a 
function of the scoring algorithm used. That estimates varied 
by a factor of 10 well illustrates the vacuity of research on burn-
out’s prevalence (2). As noted by Balon (4) (p. 82): “Numerous 
studies keep showing ever-increasing rates [of burnout] with-
out any substantial debate about what these numbers mean 
and how we should interpret them.”
Finally, Colville and Smith (1) overlooked basic similarities 
between burnout and depression. We turn here to key symp-
tom items of the MBI and compare them with the symptoms 
used to diagnose depressive disorders. The emotional exhaus-
tion (EE) subscale of the MBI includes such items as “I feel used 
up at the end of the workday” and “I feel fatigued when I get 
up in the morning and have to face another day” (5). Consider 
the symptoms of depression described in the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 
(6). They include sleep disturbance, fatigue, and loss of energy. 
The DSM-5 notes that in depression, “often insomnia or fatigue 
is the presenting complaint” (p. 162). Consider another EE 
item: “I feel like I’m at the end of my rope.” It suggests severely 
depressed mood, a cardinal DSM-5 criterion for depression (6).
In our structural equation modeling research (5), we found 
that latent EE correlates 0.85 with latent depression, control-
ling for measurement error, and item overlap. Latent deper-
sonalization was a little less closely correlated with latent 
depression, 0.70, although related closely enough to suggest 
overlap. Consider some exemplary depersonalization items, 
such as “I worry that this job is hardening me emotionally” or 
“I don’t really care what happens to some patients.” The DSM-5 
observes that withdrawal, increased irritability, and “not caring 
anymore” often accompany depressive affect (p. 163).
The third component of burnout, nonconsidered by Colville 
and Smith (1), is (diminished) personal accomplishment (PA). 
Although we found that latent PA represented the burnout 
dimension least related to latent depression, the correlation 
was still moderate, –0.49. According to DSM-5 (p. 164), “nega-
tive evaluations of one’s worth” and feelings of failure—what 
diminished PA is about—are symptoms of depression.
The view that burnout overlaps with depression has been 
increasingly supported in recent years (2). The study by 
Colville and Smith (1) in no way weakens this view.
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We thank Schonfeld et al (1) for their comments on our letter (2) on the degree to which depression and burn-out overlap in ICU staff. However, although we agree 
that these two forms of distress are associated, that does not mean 
they are the same thing—correlation is not the same as overlap.
In our survey of 218 staff (3), only five met criteria for burn-
out and depression, whereas 62 met burnout criteria without 
meeting depression criteria and two met depression criteria 
without meeting burnout criteria. We inferred from this that 
high-risk burnout symptoms are significantly more common 
in ICU staff than symptoms of clinical depression and that 
burnout and depression are not the same thing. Interestingly, 
another recent study of 5,897 practicing physicians (4), using 
different measures of depression and burnout, has reported 
that burnout was five times as common as depression, suggest-
ing that this finding may be more widely applicable to health 
professionals who are functioning well enough to be at work.
The definition we used for burnout was not “arbitrary.” It was 
based on research by Schaufeli et al (5) which shows that emo-
tional exhaustion and depersonalization are most strongly asso-
ciated with a clinical diagnosis of burnout and is consistent with 
previous research practice in this field (6). However, we agree 
that there needs to be greater evidence-based consensus on the 
dichotomous classification of burnout. We would also support 
the idea that it might be useful to screen staff with high rates of 
burnout symptoms for depression, as well as anxiety and post-
traumatic stress (which were both more prevalent in our sample 
than depression) and moral distress, which we did not measure.
Even if, for argument’s sake, burnout is viewed as a “sub-
clinical” form of depression, that is not the same thing as 
saying there is no point measuring it. There is now a huge liter-
ature supporting the construct of burnout and demonstrating 
